The controlling shareholder of Star Lake Bioscience (600866.SH) has completed the increase in holding of the company's 0.68% stake.
Star Lake Technology (600866.SH) has announced that its controlling shareholder, Guangdong Guangxin Holdings Group Co., Ltd. (abbreviated as...)
Star Lake Bioscience (600866.SH) announced that the controlling shareholder Guangdong Guangxin Holding Group Co., Ltd. (referred to as "Guangxin Group") has completed the implementation of its share increase plan. Guangxin Group has acquired a total of 11.3018 million shares of the company through centralized competitive bidding on the Shanghai Stock Exchange, representing 0.68% of the total share capital of the company. The total amount of the share increase is RMB 51.2965 million. This share increase plan has been completed.
Related Articles

CITIC SEC: Computing power is in high demand, driven by both Capex and Token needs, while AI applications are approaching a turning point in value reassessment.

"340,000 investors recover 100% of assets, SEC drops lawsuit against Gemini (GEMI.US), signaling a loosening of cryptocurrency regulation in the US?"

Intel Corporation relies on outsourcing revenue to support its business, while Wells Fargo & Company sees potential in AMD seizing market share.
CITIC SEC: Computing power is in high demand, driven by both Capex and Token needs, while AI applications are approaching a turning point in value reassessment.

"340,000 investors recover 100% of assets, SEC drops lawsuit against Gemini (GEMI.US), signaling a loosening of cryptocurrency regulation in the US?"

Intel Corporation relies on outsourcing revenue to support its business, while Wells Fargo & Company sees potential in AMD seizing market share.

RECOMMEND

Paul Chan Says Hong Kong Has Licensed 11 Virtual Asset Exchanges, Stablecoin Licenses Expected Later This Year
22/01/2026

Ministry Of Finance And Other Departments Introduce Comprehensive Fiscal And Financial Policies To Boost Domestic Demand
22/01/2026

Capital Migration: Five Years On, An In‑Depth Analysis Of China’s 11 High‑Growth Venture Capital Tracks In 2025
22/01/2026


